.

Clovis Oncology reported $-57478000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Agenus AGEN:US $ -43.28M 8.94M
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
Arrowhead Research ARWR:US $ -70306000 114.46M
Astrazeneca AZN:US $ 3562M 625M
AstraZeneca AZN:LN 292568.43M 24571.33M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Clovis Oncology CLVS:US $ -57.48M 9.04M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
GlaxoSmithKline GSK:LN 244700M 1400M
Halozyme Therapeutics HALO:US $ 46.61M 29.84M
Insmed INSM:US $ -98081000 92K
Mirati Therapeutics MRTX:US $ -176.51M 7.08M
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Veracyte VCYT:US $ -0.94M 7.75M
YTE INCY:US $ 276.8M 132.69M